NeuraLight

NeuraLight, a health care startup founded in 2021 and headquartered in Israel, is making waves with its mission to digitize neurology. The company's slogan "Digitizing Neurology" captures its innovative approach to developing a software-based platform for eye movement analysis. This platform serves as an objective and sensitive tool in the realm of neurodegenerative diseases. One of the standout achievements of NeuraLight is the successful utilization of its platform in several CNS clinical trials. These trials have demonstrated the platform's efficacy in utilizing eye movement analysis to differentiate patients from healthy subjects, stratify different subgroups, and monitor disease progression. With a recent influx of funding, NeuraLight secured a significant $25.00M Series A investment on 24 May 2022. The investors contributing to this round include prominent names such as Breyer Capital, Samsung NEXT, Alumni Ventures Blockchain Fund, Koch Disruptive Ventures, VSC Ventures, Asaf Fybish, David Golan, Castor Ventures, Lily Sarafan, and Chris Mansi. NeuraLight's innovative approach, combined with its compelling success in clinical trials, positions the company as a promising player in the intersection of healthcare and technology. As the company continues to develop its platform and garner support from notable investors, it holds potential to make a significant impact in the field of neurology and neurodegenerative diseases.